07:26 AM EDT, 05/13/2025 (MT Newswires) -- Legend Biotech ( LEGN ) reported a Q1 adjusted net loss Tuesday of $0.07 per share, narrowing from a loss of $0.23 a year earlier.

One analyst surveyed by FactSet expected a loss of $0.21 per share.

Revenue for the quarter ended March 31 was $195.1 million, up from $94 million a year earlier.

Analysts surveyed by FactSet expected $193.6 million.

Shares of the company were up more than 1.9% in recent Tuesday premarket activity.

Price: 33.00, Change: +0.62, Percent Change: +1.91